MEDEX | MEDHX | MEDEX / MEDHX | |
Total Expense Ratio | 1.31 | 0.70 | 187% |
Annual Report Gross Expense Ratio | 1.32 | 0.71 | 186% |
Fund Existence | 16 years | 19 years | - |
Gain YTD | 1.508 | 1.713 | 88% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7B | 7B | 100% |
Annual Yield % from dividends | 6.28 | 6.89 | 91% |
Returns for 1 year | 6.50 | 7.06 | 92% |
Returns for 3 years | 18.15 | 20.24 | 90% |
Returns for 5 years | 14.22 | 17.74 | 80% |
Returns for 10 years | 27.76 | 35.62 | 78% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GTLIX | 20.21 | 0.03 | +0.15% |
Glenmede Disciplined US Eq Ptf InstlShrs | |||
ACVUX | 9.86 | N/A | N/A |
American Century International Value I | |||
LGCVX | 17.61 | N/A | N/A |
Lord Abbett Global Equity R5 | |||
INGFX | 34.46 | N/A | N/A |
Invesco Oppenheimer International Gr R5 | |||
JSIGX | 20.39 | N/A | N/A |
Jacob Small Cap Growth Institutional |